Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: ResMed, Inc.

Market Cap 28.13B 24.3B 22.39B 20.96B 39.27B 2,674B 39.88B 264B 103B 1,301B 106B 103B 4,506B P/E Ratio 2026 *
18.4x
P/E Ratio 2027 * 16.6x
Enterprise Value 27.27B 23.55B 21.71B 20.32B 38.08B 2,592B 38.67B 256B 99.92B 1,262B 102B 100B 4,369B EV / Sales 2026 *
4.82x
EV / Sales 2027 * 4.35x
Free-Float
75.61%
Yield 2026 *
1.25%
Yield 2027 * 1.38%
1 day+1.24%
1 week-0.64%
Current month+2.21%
1 month-3.75%
3 months-15.62%
6 months-22.79%
Current year-19.13%
1 week 191.72
Extreme 191.72
197.34
1 month 180.26
Extreme 180.265
211.74
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
06-08Fiscal year

Chief Executive Officer

14,973 0.0103%
06-01Tax

General Counsel

-269 0.0002%
05-07Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+1.24%-0.64%-21.88%-9.31% 28.13B
-1.33%-0.73%+16.53%-10.78% 174B
-0.45%-2.61%-19.74%+30.31% 146B
-0.38%-2.28%-10.25%-25.35% 127B
-0.55%-3.38%-52.97%-8.31% 69.72B
-0.76%-0.99%+13.25%-2.62% 49.01B
+0.67%-0.60%-24.14%-34.78% 44.74B
+0.22%-4.13%+10.90%+8.65% 36.67B
-1.17%-2.69%+3.87%+35.04% 34.91B
+1.04%+0.79%-9.79%-16.21% 29.65B
Average -0.15%-1.95%-9.42%-3.34% 74.03B
Weighted average by Cap. -0.48%-1.93%-7.82%-2.92%

Financials

2026 *2027 *
Net sales 5.65B 4.88B 4.5B 4.21B 7.89B 537B 8.01B 53.13B 20.71B 262B 21.22B 20.76B 906B 6.1B 5.27B 4.86B 4.55B 8.52B 580B 8.65B 57.37B 22.37B 282B 22.91B 22.42B 978B
Net income 1.55B 1.34B 1.23B 1.16B 2.17B 147B 2.2B 14.57B 5.68B 71.74B 5.82B 5.7B 248B 1.7B 1.47B 1.36B 1.27B 2.38B 162B 2.42B 16.01B 6.24B 78.82B 6.39B 6.26B 273B
Net Debt -859M -742M -684M -640M -1.2B -81.66B -1.22B -8.07B -3.15B -39.75B -3.22B -3.16B -138B -1.58B -1.36B -1.26B -1.18B -2.2B -150B -2.24B -14.83B -5.78B -72.99B -5.92B -5.79B -253B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
12/06/26 194.78 $ +1.24% 1,085,732
11/06/26 192.39 $ -0.61% 1,070,950
10/06/26 193.57 $ -1.71% 1,039,160
09/06/26 196.94 $ +1.97% 1,024,460
08/06/26 193.14 $ -1.48% 1,033,936
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
194.78USD
Average target price
270.60USD
Spread / Average Target
+38.93%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!